3 Health Services Stocks Driving The Industry Higher

One out of the three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 25 points (0.1%) at 17,526 as of Monday, May 23, 2016, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,545 issues advancing vs. 1,371 declining with 153 unchanged.

The Health Services industry currently sits up 0.3% versus the S&P 500, which is down 0.1%. On the negative front, top decliners within the industry include Cigna ( CI), down 4.2%, Universal Health Services ( UHS), down 1.6% and DaVita HealthCare Partners ( DVA), down 0.8%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Grifols ( GRFS) is one of the companies pushing the Health Services industry higher today. As of noon trading, Grifols is up $0.29 (1.9%) to $15.13 on heavy volume. Thus far, 1.9 million shares of Grifols exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $14.99-$15.19 after having opened the day at $14.99 as compared to the previous trading day's close of $14.84.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Grifols, S.A., a biopharmaceutical company, develops, manufactures, and distributes plasma derivative products in the United States, Canada, Spain, rest of the European Union, and internationally. Grifols has a market cap of $9.9 billion and is part of the health care sector. Shares are down 8.5% year-to-date as of the close of trading on Friday. Currently there is 1 analyst who rates Grifols a buy, 1 analyst rates it a sell, and 1 rates it a hold.

TheStreet Ratings rates Grifols as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and expanding profit margins. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Grifols Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading, Edwards Lifesciences ( EW) is up $1.51 (1.5%) to $100.62 on average volume. Thus far, 881,003 shares of Edwards Lifesciences exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $99.60-$100.97 after having opened the day at $99.62 as compared to the previous trading day's close of $99.11.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences has a market cap of $20.7 billion and is part of the health care sector. Shares are up 25.5% year-to-date as of the close of trading on Friday. Currently there are 13 analysts who rate Edwards Lifesciences a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Edwards Lifesciences as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Edwards Lifesciences Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading, Express Scripts ( ESRX) is up $0.70 (1.0%) to $73.57 on average volume. Thus far, 1.9 million shares of Express Scripts exchanged hands as compared to its average daily volume of 4.5 million shares. The stock has ranged in price between $72.39-$73.95 after having opened the day at $72.82 as compared to the previous trading day's close of $72.87.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States, Canada, and Europe. The company operates through two segments, PBM and Other Business Operations. Express Scripts has a market cap of $45.8 billion and is part of the health care sector. Shares are down 16.6% year-to-date as of the close of trading on Friday. Currently there are 8 analysts who rate Express Scripts a buy, 1 analyst rates it a sell, and 8 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, notable return on equity, good cash flow from operations and reasonable valuation levels. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Express Scripts Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

More from Markets

Stocks Fall Amid Trade Tensions, Ahead of Alphabet Earnings

Stocks Fall Amid Trade Tensions, Ahead of Alphabet Earnings

Hasbro Surges After Q2 Sales Beat, Upbeat Sector Outlook

Hasbro Surges After Q2 Sales Beat, Upbeat Sector Outlook

Video: Here Is How Tech Earnings Could Affect the Broader Stock Market

Video: Here Is How Tech Earnings Could Affect the Broader Stock Market

Fiat Slides After CEO Sergio Marchionne Leaves Automaker Amid Failing Health

Fiat Slides After CEO Sergio Marchionne Leaves Automaker Amid Failing Health

Papa John's Adopts 'Poison Pill' as Fallout from Schnatter's Resignation Spreads

Papa John's Adopts 'Poison Pill' as Fallout from Schnatter's Resignation Spreads